GRAL vs GH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GH Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Guardant Health, Inc. Common Stock (GH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus GH at N/M Forward P/E and -39.4% operating margin (+36.1% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against GH sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | GRAL Revenue | GH Revenue | GRAL Op. Margin | GH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $90M | N/A | -102.5% | GH |
| FY2019 | N/A | $210M | N/A | -38.4% | GH |
| FY2020 | N/A | $290M | N/A | -88.9% | GH |
| FY2021 | N/A | $370M | N/A | -110.0% | GH |
| FY2022 | N/A | $450M | N/A | -121.1% | GH |
| FY2023 | $90M | $560M | -1627.6% | -100.1% | GH |
| FY2024 | $130M | $740M | -1743.0% | -60.0% | GH |
| FY2025 | $150M | $980M | -382.0% | -44.5% | GH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GRAL | GH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $20.5B | Larger Scale | GH |
| Trailing P/E Ratio Valuation | 1.1x | N/M | Lower Multiple | GRAL |
| Forward P/E Ratio Valuation | 1.1x | N/M | Lower Multiple | GRAL |
| Revenue Growth (YoY) Growth | +3.7% | +36.1% | Higher Growth | GH |
| Operating Margin (TTM) Profitability | -332.0% | -39.4% | Higher Margin | GH |
| Net Profit Margin Profitability | -243.8% | -37.9% | Higher Margin | GH |
| Return on Equity (ROE) Capital Efficiency | -17.3% | 0.0% | Higher ROE | GH |
| 52-Week Range Position Momentum | 51% ($42โ$166) | 60% ($75โ$191) | Stronger Trend | GH |
| Beta / 30D Volatility Risk Regime | 3.09ฮฒ ยท 99% Vol | 1.32ฮฒ ยท 56% Vol | Lower Realized Risk | GH |
| Unified Institutional Score Composite Signal | 54.5 / 100 (HOLD) | 48.4 / 100 (HOLD) | Higher Composite | GRAL |